Abstract
Paroxysmal Nocturnal Haemoglobinuria is a rare haematological disease causing acquired haemolytic anaemia. The clinical spectrum of the disease starts from anaemia (microcytic to macrocytic) to pancytopenia and aplastic anaemia. The disease may present at any age group but the most common prevalence is in the third and fourth decade. This disease is not diagnosed commonly as the classical haematuria is not present in majority. We present the case of 15-year-old boy who presented with skin rash all over body and weakness, which on investigation was diagnosed as case of PNH. Skin manifestation of PNH are very uncommon and rarely reported in literature. A high index of suspicion is necessary for the diagnosis.
Keywords: paroxysmal nocturnal haemoglobinuria, ecchymosis, haemolysis, haemoglobinuria, CD55 and CD59.
References
- L. Rietschel, C.W. Lewis, R.A. Simmons, et al. Skin lesions in paroxysmal nocturnal haemoglobinuria Arch Dermatol, 114 (1978), pp. 560-563.
- M. White, K. Watson, R. Arya, et al. Hae-morrhagic bullae in a case of paroxysmal nocturnal haemoglobinuria Clin Exp Dermatol, 28 (2003), pp. 504-505.
- Cholez, J.L. Schmutz, C. Hulin, et al. Cutaneous necrosis during paroxysmal nocturnal haemoglobinuria: role of parvovirus B19?J Eur Acad Dermatol Venereol, 19 (2005), pp. 381-382
- Alves, H. Barreiros, D. Matos, R. Coelho Cutaneous thrombosis related to paroxysmal nocturnal haemoglobinuria: clinical report Dermatol Online J, 18 (2012), p. 13
- Salim, O.K. Yücel, et al. Cutaneous thrombosis as the presenting finding of paroxysmal nocturnal haemoglobinuriaBr J Haematol, 171 (2015), p. 296. [Epub 2015 Jul 23]
- A. Brodsky Paroxysmal nocturnal hae-moglobinuria Blood, 124 (2014), pp. 2804-2811
- SchrezenmeierH, Muus P, Socié G, etal. Baseline characteristics and disease burden in patients in the international paroxysmal nocturnal haemoglobinuria registry. Haematologica 2014.
- LindorferMA, Pawluczkowycz AW, et al. A novel approach to preventing the haemolysis of paroxysmal nocturnal haemoglobinuria: both complement-mediated cytolysis and C3 deposition are blocked by a monoclonal antibody specific for the alternative pathway of complement. Blood 2010;115(11):2283-2291.
- RisitanoAM, Notaro R, Pascariello C, et al. The complement receptor 2/factor H fusion protein TT30 protects paroxysmal nocturnal haemoglobinuria erythrocytes from complement-mediated haemolysis and C3 fragment. Blood 2012;119(26):6307-6316.
Corresponding Author
Dr Gangadhar
07 Mithuna Block, Police Quarters, Tajsultanpur. Gulbarga, Karnataka- 585104, India
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
DOI: https://dx.doi.org/10.18535/jmscr/v6i6.182
